HIM
PRPH

Hillsdale Investment Management’s ProPhase Labs PRPH Stock Holding History

Hillsdale Investment Management’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,003
Closed -$113K – 607
2022
Q3 		$113K Sell
1,003
-6,147
-86% -$715K 0.01% 414
2022
Q2 		$907K Buy
+7,150
New +$629K 0.07% 188

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return

Hillsdale Investment Management's PRPH Position: Q4 2022 in Review

Hillsdale Investment Management sold out of ProPhase Labs (PRPH) in Q4 2022, closing a stake of 1,003 shares — an estimated $113K sold.

Hillsdale Investment Management first reported a position in PRPH in Q2 2022 and held it in 2 quarters. The position peaked at $907K in Q2 2022. 51 funds tracked by Wall St. Rank hold PRPH as of Q4 2022.

  • Hillsdale Investment Management reported no remaining ProPhase Labs position as of Q4 2022 after selling out during the quarter.
  • Hillsdale Investment Management sold 1,003 ProPhase Labs shares in Q4 2022, an estimated $113K.
  • Hillsdale Investment Management first reported a position in ProPhase Labs in Q2 2022 and held it in 2 quarters.
  • Hillsdale Investment Management's ProPhase Labs position peaked at $907K in Q2 2022.
  • 51 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2022.

Based on Hillsdale Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.